Tiny study probes key player in blood vessel health
NCT ID NCT02086253
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at how a natural chemical called endothelin-1 affects the widening of arteries in response to increased blood flow. Eight healthy young men received drugs that block specific receptors for endothelin-1 to see how their arteries reacted. The goal was to better understand blood vessel function, which could help explain problems in conditions like high blood pressure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BQ-788 and/or BQ-123
- What this could lead to
- If successful, this could help explain why blood vessels don't widen properly in conditions like high blood pressure, pointing toward new treatment targets.
- What could go wrong
- This is a very small, early study in only 8 healthy young men, so results may not apply to older or sicker people. It is designed to gather knowledge, not test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY CONDITIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU - Hôpitaux de Rouen
Rouen, Normandy, 76031, France